Geodon (Roerig)
Welcome to the PulseAid listing for the Geodon drug offered from Roerig. This Atypical Antipsychotic [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Roerig |
| NON-PROPRIETARY NAME: | ziprasidone mesylate |
| SUBSTANCE NAME: | ZIPRASIDONE MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Atypical Antipsychotic [EPC] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2017-07-24 |
| END MARKETING DATE: | 0000-00-00 |
Geodon HUMAN PRESCRIPTION DRUG Details:
| Item Description | Geodon from Roerig |
| LABELER NAME: | Roerig |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 20(mg/mL) |
| START MARKETING DATE: | 2017-07-24 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0049-1203_e14565ec-7453-4081-91ef-8764e7c9112f |
| PRODUCT NDC: | 0049-1203 |
| APPLICATION NUMBER: | NDA020919 |
Other ZIPRASIDONE MESYLATE Pharmaceutical Manufacturers / Labelers:
